Established in 1997, Dallas Psychiatry & TMS Center offers cutting edge treatments like Neurostar TMS Therapy, a non-systemic treatment for depression and GeneSightRx testing, a program that tailors medication treatments to the individual and offers clinicians insight to better understand how patients may metabolize or respond to medication prescribed to them. The NeuroStar TMS Therapy system is the first TMS Therapy® device cleared by the FDA for the treatment of depression. TMS Therapy is a non-systemic (does not circulate in the bloodstream throughout the body) and non-invasive (does not involve surgery) form of neuromodulation, which stimulates nerve cells in an area of the brain that is linked to depression, by delivering highly focused MRI- strength magnetic pulses. Patients being treated by NeuroStar TMS Therapy do not require anesthesia or sedation and remain awake and alert. It is a 20-minute outpatient procedure that is prescribed by a psychiatrist and performed in a psychiatrist's office. The treatment is typically administered daily for 6 weeks.